Can zebrafish provide the key to new treatments for Alzheimer’s disease? Petronella Kettunen hopes so. She will now receive SEK 1.75 million from the Torsten Söderberg Foundation for a unique research project.
Petronella Kettunen at the Institute of Neuroscience and Physiology, Sahlgrenska Academy, has developed a new model in which zebrafish is used to study Alzheimer’s disease. The purpose of the studies is to better understand the disease – but the zebrafish model will also be used to test future drugs against Alzheimer’s disease.
A total of four researchers at the Sahlgrenska Academy receive grants from the Foundation this call. Besides Petronella Kettunen, Gunnar C. Hansson receives SEK two million for his research on defects in the colon inner mucus layer in ulcerative colitis, Kristina Eriksson gets a million and a half for her project about how the natural immune system of the placenta and the newborn works at a viral infection, and Jan-Åke Liljeqvist gets SEK three million in the development of vaccines against herpes simplex virus type 2 infection.
